0001104659-23-059151.txt : 20230511
0001104659-23-059151.hdr.sgml : 20230511
20230511161619
ACCESSION NUMBER: 0001104659-23-059151
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230501
FILED AS OF DATE: 20230511
DATE AS OF CHANGE: 20230511
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Poll Claire
CENTRAL INDEX KEY: 0001836820
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38067
FILM NUMBER: 23911267
MAIL ADDRESS:
STREET 1: C/O VERONA PHARMA PLC
STREET 2: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Verona Pharma plc
CENTRAL INDEX KEY: 0001657312
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
BUSINESS PHONE: 011-44-0-2032834200
MAIL ADDRESS:
STREET 1: 3 MORE LONDON RIVERSIDE
CITY: LONDON
STATE: X0
ZIP: SE1 2RE
4/A
1
tm2315205-2_4seq1.xml
OWNERSHIP DOCUMENT
X0407
4/A
2023-05-01
2023-05-03
0
0001657312
Verona Pharma plc
VRNA
0001836820
Poll Claire
3 MORE LONDON RIVERSIDE
LONDON
X0
SE1 2RE
UNITED KINGDOM
0
1
0
0
General Counsel
1
Ordinary Shares
2023-05-01
4
M
0
8328
A
1987391
D
Restricted Share Units
2023-05-01
4
M
0
8328
0.00
D
2029-03-29
Ordinary Shares
8328
0
D
Reported securities are represented by American Depositary Shares ("ADSs") (unless otherwise indicated), each of which represents eight (8) Ordinary Shares of the Issuer.
Each Restricted Share Unit represented a contingent right to receive one (1) Ordinary Share of the Issuer (which may be represented by ADSs, each of which represents eight (8) Ordinary Shares of the Issuer) subject to certain time- and performance-based vesting criteria.
Consists of (i) 1,641,672 Ordinary Shares underlying Restricted Share Units (each of which represents a contingent right to receive one (1) Ordinary Share of the Issuer) (which are represented by 205,209 ADSs); (ii) 345,712 Ordinary Shares underlying 43,214 ADSs; and (iii) 7 Ordinary Shares.
This Form 4/A is being filed to report the vesting of certain previously reported Restricted Share Units which was inadvertently omitted in the Form 4 filed on May 3, 2023. The aggregate total in column 5 of Table I hereof reflects the total aggregate holdings after accounting for the sales reported in the Form 4 filed on May 3, 2023.
/s/ Claire Poll
2023-05-11